Please assess the completion status of the following clinical trial:

Trial Title: Oncologic Impact of Splenectomy-omitting Radical Pancreatectomy in Well-selected Left-sided Pancreatic Cancer

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Ductal adenocarcinoma~2. Age ≥20 and ≤80~3. General performance status: the Karnofsky score\> 70% or ECOG 0-1~4. Potentially Curative resection~5. Tumor size \< 3cm~6. Pancreatic cancer located on neck or body portion~7. No invasion to spleen or spleen hilum~8. No combined resection except Lt. adrenal gland~9. Distance more than 5cm (≥5cm) between tumor lateral margin and spleen hilum~Exclusion Criteria:~1. Unresectable or locally advanced, metastatic case~2. Patients who do not want surgery~3. ASA (American society of anesthesiologists' physical status classification) score: ≥3~4. Patients with drug or alcohol addiction~5. Patients showing low compliance~6. Patients who not want to involve the clinical trial~7. Patients who are unable to read or understand the informed consent, sign a consent form (eg, mental retardation, blindness, illiteracy, foreign, etc.)

- Gender: ALL
- Minimum Age: 20 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- RAMPS (Type: EXPERIMENTAL): Radical Antegrade Modular Pancreatectomy with Splenectomy
- RAMP (Type: ACTIVE_COMPARATOR): Radical Antegrade Modular Pancreatectomy without splenectomy

Based on this trial design, predict the completion outcome and termination type (if applicable).